The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000642381
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
7/05/2026
Date registered
Help: Date registered
27/05/2026
Date last updated
Help: Date last updated
9/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
27/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
The ProActive Trial: getting prostate cancer survivors active using the Cancer Rehabilitation to Recreation (CaReR) Framework
Scientific title
A feasibility trial of a new model of care (ProActive) to improve physical activity of people with prostate cancer using the Cancer Rehabilitation to Recreation (CaReR) Framework
Additional trial identifiers [1] 317208 0
nil
Universal Trial Number (UTN)
U1111-1340-2773
Trial acronym
ProActive
Related trial records

Health condition
Health condition(s) studied:
Prostate Cancer 341795 0
Condition category
Condition code
Cancer 337869 337869 0 0
Prostate
Physical Medicine / Rehabilitation 337870 337870 0 0
Physiotherapy

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
What is the intervention: ProActive (Getting Prostate cancer survivors ACTIVE using the Cancer Rehabilitation to Recreation Framework). Physiotherapist-led exercise support using a stepped approach to care. Patients are referred to hospital-based rehabilitation, community-based exercise/fitness group or local gym following a comprehensive assessment by the physiotherapist. Patients are referred to the most appropriate service depending on their needs whereby those who have high levels of symptoms, low confidence to exercise and low functional level will be referred to hospital based rehabilitation programs. If patients display higher levels of function, confidence and lower syptoms, they will be referred to community-based exercise with a trained exercise professional or local gym. The comprehensive assessment includes review of patients cancer and other relevant medical history, exercise history, mobility, symptoms, confidence to exercise and exercise capacity using the 6-minute walk or 2 minute step test, 5 times sit to stand test, repetition max testing, timed up and go test and other relevant balance tests as indicated. Clinical decision making is guided by the Personalised Exercise Rehabilitation for Cancer Survivorship (PERCS) algorithm.
Types of exercises: Treadmill walking, stationary bike, pin-loaded weights machines, resistance bands, body weight exercise, free weights
Mode of delivery; will depend on location of delivery. Rehabilitation and fitness services may be delivered 1:1 or in a group depending on individual needs. Recreation will be individual
Who delivers it and their relevant expertise: Physiotherapist trained in oncology and exercise, and behavioural counselling to provide intervention. Local fitness providers who have received education in exercise oncology and supported by a cancer physiotherapist may provide part of the intervention in the community with appropriate patients based on physiotherapist screening.
How it is delivered: face to face or phone/online depending on patient preference, individual. Group sessions may be conducted in the community if patient is referred to a local rehabilitation program depending on their needs.
How often and for how long: 4 consultation sessions(1x 1 hour, 3x 30 minutes) in 6-month period. These will have a focus on exercise behaviour change and will include exercise demonstration and practice, motivational interviewing style exercise counselling including advice on how to stay active and goalsetting
If patients referred to an exercise service, they may participate in supervised exercise 2 to 3 times weekly for periods of 8 to 12 weeks. Supervised exercise will aim to be delivered at moderate intensity and monitored using BORG/RPE scales
Where it is delivered: Hospital inpatient/outpatient clinic setting/home, local gym
Adherence: Physiotherapy session attendance recorded and an audit of exercise completed in the community
Intervention code [1] 333980 0
Treatment: Other
Intervention code [2] 333981 0
Lifestyle
Description of the comparator or control
What is the intervention: Usual care advice and written materials (Eastern Health service brochures, Prostate Cancer Foundation Exercise and Cancer handout, Cancer Council Exercise booklet)
Who delivers it and their relevant expertise: Prostate Cancer Nurse Consultant
How it is delivered: (e.g. face to face/phone, individual)
How often and for how long: at least 1 30-minute consult
Where it is delivered: Hospital
Adherence: review of medical record
Control group
Active

Outcomes
Primary outcome [1] 345333 0
Recruitment:
Timepoint [1] 345333 0
at the end of the recruitment period
Primary outcome [2] 345334 0
Retention
Timepoint [2] 345334 0
6-months from baseline
Primary outcome [3] 345336 0
Intervention adherence
Timepoint [3] 345336 0
6-months from baseline
Secondary outcome [1] 461318 0
Acceptability
Timepoint [1] 461318 0
6-months from baseline
Secondary outcome [2] 461321 0
Acceptability
Timepoint [2] 461321 0
6-months from baseline
Secondary outcome [3] 461323 0
Physical Activity
Timepoint [3] 461323 0
baseline and 6-months post-enrolment
Secondary outcome [4] 461324 0
Self-efficacy for exercise
Timepoint [4] 461324 0
baseline and 6-months post-enrolment
Secondary outcome [5] 461325 0
Health-related quality of life
Timepoint [5] 461325 0
baseline and 6-months post-enrolment
Secondary outcome [6] 461326 0
ED presentations
Timepoint [6] 461326 0
6-months post enrollment
Secondary outcome [7] 461327 0
Unplanned hospital re-admissions
Timepoint [7] 461327 0
6 months post enrollment
Secondary outcome [8] 461328 0
Adverse Events
Timepoint [8] 461328 0
6-months from enrollment

Eligibility
Key inclusion criteria
Aged 18 years and over

Diagnosed with prostate cancer within the last 6-months

Able to ambulate independently with or without a walking aid

Have an Eastern Cooperative Oncology Group score of equal to or less than 2 (Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours)

Able to communicate in conversational English

Able to give written informed consent as recorded in the medical record or as assessed by their treating clinician or trial assessor.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
Have a medical condition that contraindicates exercise (e.g., severe immunocompromise; unstable angina, unstable hypertension, or unstable heart failure) or deemed at potential risk of medical deterioration as determined by the research physiotherapist and/or medical team. The physiotherapist will have experience and additional training in exercise and cancer and guided by published recommendations (23).

Have a cognitive impairment as determined by their treating clinician

Are receiving end of life care.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation will be concealed from the participant and researchers until participants have completed baseline assessment. Allocation completed by an independent researcher not involved in participant recruitment, assessment or intervention
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
permuted blocks of 3, 6 and 9 from an online computer-generated program
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
The primary outcome of this trial will be to determine whether prespecified progression criteria are met to justify progression to a full randomised trial evaluating the effectiveness of the ProActive intervention. Progression criteria will focus on trial recruitment, retention and intervention adherence and will be assessed using a traffic light system of green (go), amber (amend) and red (stop), Progression criteria were developed by the research team based off Simpson et al 2024.
Results of the primary outcome of feasibility will be reported descriptively in alignment with the prespecified progression criteria. Outcomes such as recruitment, retention, adherence rates and intervention fidelity will be reported using descriptive statistics. Safety outcomes such as adverse events will also be described.

Continuous clinical outcomes such as health-related quality of life and self-efficacy scores will be summarised using means and standard deviations as appropriate. Between-group comparisons of change scores with confidence intervals will be performed using ANCOVA models. Standard deviation estimations will be used to inform sample size calculations for a future trial.

Effect sizes, e.g., Cohen’s d and mean differences with 95% confidence intervals, will be calculated to estimate the magnitude and direction of effects to inform future trial design.

Patient acceptability questionnaires will be analysed using descriptive statistics to summarise responses across key domains (e.g., satisfaction, perceived usefulness, burden). Likert-scale items will be reported using frequencies, percentages and means where appropriate. A content analysis of open-ended responses will identify common themes related to participants' experiences and suggestions for improvement.

Interviews will be audio-recorded and transcribed verbatim. Transcripts will be provided to participants to check for accuracy in a process called member checking. If participants do not agree with the content of the transcript, they will be given the opportunity to amend it. After member checking, transcribed interviews will be de-identified and imported into qualitative analysis software. Two researchers will read the interviews and assign codes to sections of the text independently to identify themes inductively (thematic analysis) using an interpretive description approach. Next the researchers will look for connections between the themes to develop main themes and sub-themes. Once the main themes are decided upon, researchers will go back and selectively search for text on those themes.

Recruitment
Recruitment status
Recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 29489 0
Eastern Health - Box Hill
Recruitment postcode(s) [1] 45805 0
3128 - Box Hill

Funding & Sponsors
Funding source category [1] 321785 0
Charities/Societies/Foundations
Name [1] 321785 0
Eastern Health Foundation
Country [1] 321785 0
Australia
Funding source category [2] 321795 0
Government body
Name [2] 321795 0
NHMRC
Country [2] 321795 0
Australia
Primary sponsor type
University
Name
La Trobe University
Address
Country
Australia
Secondary sponsor category [1] 324644 0
None
Name [1] 324644 0
Address [1] 324644 0
Country [1] 324644 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320329 0
Eastern Health Human Research Ethics Committee
Ethics committee address [1] 320329 0
Ethics committee country [1] 320329 0
Australia
Date submitted for ethics approval [1] 320329 0
27/03/2026
Approval date [1] 320329 0
28/04/2026
Ethics approval number [1] 320329 0
LR26-023-127237

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150110 0
Dr Amy Dennett
Address 150110 0
La Trobe University-Eastern Health Academic Research Collaborative in Health,Level 2, 5 Arnold St Box Hill, VIC, 3128
Country 150110 0
Australia
Phone 150110 0
+61 390952442
Fax 150110 0
Email 150110 0
Contact person for public queries
Name 150111 0
Amy Dennett
Address 150111 0
La Trobe University-Eastern Health Academic Research Collaborative in Health,Level 2, 5 Arnold St Box Hill, VIC, 3128
Country 150111 0
Australia
Phone 150111 0
+613 90952442
Fax 150111 0
Email 150111 0
Contact person for scientific queries
Name 150112 0
Amy Dennett
Address 150112 0
La Trobe University-Eastern Health Academic Research Collaborative in Health,Level 2, 5 Arnold St Box Hill, VIC, 3128
Country 150112 0
Australia
Phone 150112 0
+613 90952442
Fax 150112 0
Email 150112 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

TypeCitationLinkEmailOther DetailsAttachment
Ethical approval    LR26-023-127237 Final Approval Apr26.pdf
Study protocol    CLEANProtocol_ProactiveTrial_V1.1.docx


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.